Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion
Clinical trial NCT02603510 · COMPLETED
Trial details
- NCT number
- NCT02603510
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2016-04-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.